Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Times cited: 1467
Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck.
Journal of Clinical Oncology.
Times cited: 398